Radio Frequency + Biologics

Celling Biosciences produces top of the line innovative biologics solutions, and alongside Thermi’s radio frequency technology, seeks to amplify the delivery of biologics and enhance integrated restorative wellness solutions for our partners across medical specialties. The merging of the Thermi product line with the cutting-edge technology of Celling Biosciences, will fast track the evolution of micro-invasive, preventive and regenerative treatments across the healthcare spectrum.

A Powerful Combination.

Celling Biosciences produces top of the line innovative biologics solutions, and alongside Thermi’s radio frequency technology, seeks to amplify the delivery of biologics and enhance integrated restorative wellness solutions for our partners across medical specialties онлайн микрозайм без отказа . The merging of the Thermi product line with the cutting-edge technology of Celling Biosciences, will fast track the evolution of micro-invasive, preventive and regenerative treatments across the healthcare spectrum.

The ART PRP Plus

The ART PRP PLUS system has an integrated filter system for the ultrafiltration of proteins from platelet poor plasma (PPP). This system processes autologous whole blood effectively and efficiently at the point of care. The system recovers the greatest percentage of platelets and growth factors by allowing selection of the platelet concentrate from user defined portions of a centrifuged stack of fluid.

The ART Two-Step

The ART Two Step PRP device features a dual-chamber design allowing the user to perform either leukocyte rich or leukocyte poor platelet-rich plasma. The product uses Celling Bioscience’s patented collection window and dial mechanism allowing precision control to achieve a high yield of platelets in a PRP volume that can be customized to the physician’s clinical requirements.

About Celling Biosciences

Celling Biosciences is a pioneer in the science, research and development of autologous cell therapy technology.  Celling products are designed to collect, process and deliver autologous cells to the patient at the point of care to accelerate the body’s natural healing process.   The Autologous Regenerative Therapies family of concentration systems recovers a high percentage of nucleated, progenitor and other cells by allowing selection of the cell concentrate from user-defined portions of a centrifuged stack. The proprietary system also features an integrated filter for the ultrafiltration of proteins from bone marrow or peripheral blood.  For more information, please visit www.cellingbiosciences.com